Discovery of orally active 1,4,5,6,8-pentaazaacenaphthylens as novel, selective, and potent covalent BTK inhibitors for the treatment of rheumatoid arthritis
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 15 January 2023 246 - Subject
- Language
- ISSN
- 0223-5234